Related Experiment Video
Updated: Feb 16, 2026

Dynamic Adhesion Assay for the Functional Analysis of Anti-adhesion Therapies in Inflammatory Bowel Disease
Published on: September 20, 2018
Inflammatory Bowel Disease Is Not a Contraindication for Bariatric Surgery
Stephanie Aelfers1, Ignace M C Janssen2, Edo O Aarts2
1Rijnstate Hospital, Arnhem, 6815 AD, Gelderland, Netherlands. stephanieaelfers@hotmail.com.
Bariatric surgery is safe and effective for patients with inflammatory bowel diseases (IBD), including ulcerative colitis (UC) and Crohn's disease (CD). Lifelong monitoring is recommended for optimal outcomes.
Area of Science:
- Gastroenterology
- Bariatric Surgery
- Inflammatory Bowel Disease
Background:
- Inflammatory bowel diseases (IBD) are often a contraindication for bariatric surgery due to theoretical risks.
- Limited data exists on the safety and efficacy of bariatric surgery in IBD patients.
Purpose of the Study:
- To assess the safety and efficacy of bariatric surgery in patients with IBD.
- To evaluate postoperative quality of life (QoL) in IBD patients undergoing bariatric surgery.
Main Methods:
- Retrospective analysis of 45 IBD patients (16 UC, 29 CD) who underwent bariatric surgery.
- Analysis of complications, mortality, reoperations, micronutrient deficiencies, weight loss, and QoL using the IBDQ.
Main Results:
- No mortality or major perioperative complications were observed.
- Significant excess weight loss (mean 62.9%) and total body weight loss (mean 26.2%) at 12 months, sustained at 24 months.
- Two major complications (bleeding, pyelonephritis) occurred in CD patients during follow-up; QoL scores were comparable between UC and CD patients.
Conclusions:
- Bariatric surgery appears safe and effective for patients with UC and CD.
- The contraindication for bariatric surgery in IBD patients warrants reevaluation.
- Close lifelong monitoring is crucial for ensuring safety and favorable outcomes.
More Related Videos
Related Concept Videos
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...

